ES8404683A1 - Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina. - Google Patents

Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.

Info

Publication number
ES8404683A1
ES8404683A1 ES520982A ES520982A ES8404683A1 ES 8404683 A1 ES8404683 A1 ES 8404683A1 ES 520982 A ES520982 A ES 520982A ES 520982 A ES520982 A ES 520982A ES 8404683 A1 ES8404683 A1 ES 8404683A1
Authority
ES
Spain
Prior art keywords
thiadiazoles
substituted diamino
formula
substituted
diamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520982A
Other languages
English (en)
Spanish (es)
Other versions
ES520982A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES520982A0 publication Critical patent/ES520982A0/es
Publication of ES8404683A1 publication Critical patent/ES8404683A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES520982A 1982-03-29 1983-03-25 Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina. Expired ES8404683A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (2)

Publication Number Publication Date
ES520982A0 ES520982A0 (es) 1984-05-16
ES8404683A1 true ES8404683A1 (es) 1984-05-16

Family

ID=23429274

Family Applications (3)

Application Number Title Priority Date Filing Date
ES520982A Expired ES8404683A1 (es) 1982-03-29 1983-03-25 Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.
ES527685A Expired ES8505977A1 (es) 1982-03-29 1983-11-30 Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina
ES527686A Expired ES8505978A1 (es) 1982-03-29 1983-11-30 Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES527685A Expired ES8505977A1 (es) 1982-03-29 1983-11-30 Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina
ES527686A Expired ES8505978A1 (es) 1982-03-29 1983-11-30 Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.

Country Status (30)

Country Link
JP (2) JPS58180477A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880002209B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT386599B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU557577B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE896291A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH660880A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS250240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD219768A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3311281A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK166677B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES8404683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2542741B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB2117769B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU196386B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE55596B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL68259A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1164633B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU84716A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8700942A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8301063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO163055C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ203726A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07356A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT76459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE461040B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (2) SU1419518A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU44849B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA832154B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW7683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
LU84716A1 (fr) 1983-12-05
AT386599B (de) 1988-09-12
GB2117769B (en) 1985-08-29
AU1290783A (en) 1983-10-06
ES527685A0 (es) 1985-06-16
SE8301725L (sv) 1983-11-25
ES527686A0 (es) 1985-06-16
NO163055B (no) 1989-12-18
GB2149406A (en) 1985-06-12
NO163055C (no) 1990-03-28
MY8700942A (en) 1987-12-31
GB2149406B (en) 1986-01-02
SE8704689D0 (sv) 1987-11-25
ES520982A0 (es) 1984-05-16
NO831100L (no) 1983-09-30
SU1355123A3 (ru) 1987-11-23
CS250240B2 (en) 1987-04-16
ES8505977A1 (es) 1985-06-16
IL68259A0 (en) 1983-06-15
AU557577B2 (en) 1986-12-24
KR840004095A (ko) 1984-10-06
GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-27
DD219768A5 (de) 1985-03-13
GB2117769A (en) 1983-10-19
IT8348005A0 (it) 1983-03-28
CH655111A5 (de) 1986-03-27
NL8301063A (nl) 1983-10-17
IE55596B1 (en) 1990-11-21
DK81192A (da) 1992-06-18
OA07356A (fr) 1984-08-31
NZ203726A (en) 1986-05-09
HU188742B (en) 1986-05-28
DE3311281A1 (de) 1983-11-24
IT1164633B (it) 1987-04-15
HU196386B (en) 1988-11-28
ES8505978A1 (es) 1985-06-16
AU6327286A (en) 1987-01-08
FR2597867A1 (fr) 1987-10-30
SE461040B (sv) 1989-12-18
CH660880A5 (de) 1987-05-29
JPH06135925A (ja) 1994-05-17
DK81192D0 (da) 1992-06-18
FR2542741B1 (fr) 1989-12-08
GB8308518D0 (en) 1983-05-05
YU74483A (en) 1986-02-28
YU44849B (en) 1991-04-30
JPS58180477A (ja) 1983-10-21
IE830686L (en) 1983-09-29
SU1419518A3 (ru) 1988-08-23
PT76459A (en) 1983-04-01
DK141383D0 (da) 1983-03-28
PT76459B (en) 1986-03-11
BE896291A (fr) 1983-09-28
DD210909A5 (de) 1984-06-27
DK141383A (da) 1983-09-30
AU586037B2 (en) 1989-06-29
KR880002209B1 (ko) 1988-10-18
SE8301725D0 (sv) 1983-03-28
GB8432809D0 (en) 1985-02-06
ZW7683A1 (en) 1984-01-04
ZA832154B (en) 1983-12-28
ATA111083A (de) 1988-02-15
DK166677B1 (da) 1993-06-28
FR2597867B1 (fr) 1989-12-08
CS250229B2 (en) 1987-04-16
SE8704689L (sv) 1987-11-25
SE464302B (sv) 1991-04-08
JPH0568472B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-09-29
FR2542741A1 (fr) 1984-09-21

Similar Documents

Publication Publication Date Title
ES8404993A1 (es) Procedimiento para preparar derivados de piridina
PL295911A1 (en) Method of obtaining imidazo-condensed iso- ane heterocyclic compounds
ES8602721A1 (es) Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina.
EP0251299A3 (en) Cephalosporin compounds, processes for their preparation and antibacterial agents
IE840182L (en) Des-proline vasopressin antagonists
CA2038848A1 (en) Hydantoin derivatives
ES8801289A1 (es) Un metodo para preparar derivados de cefem
ES8404683A1 (es) Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.
EP0107733A4 (en) CYCLOALIPHATIC MEDICINE COMPOSITIONS.
CA1228067A (en) 3,4-DIAMINO-1,2,5-THIADIAZOLE SUBSTITUTION DERIVATIVES, ANTAGONISTS FOR H.SUB.2 HISTAMINE RECEPTORS
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
ES8702881A1 (es) Un procedimiento para la preparacion de etanodiimidamidas
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
SE321467B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES8504750A1 (es) Un procedimiento para preparar compuestos heterociclicos
ES8200880A1 (es) Procedimiento para la obtencion de nuevos tioles
PH20505A (en) 1-acetonyl-2-(phenylimino)imidazolines and salts thereof and pharmaceutical compositions containing them
ZA811316B (en) Cephalosporins,processes for their preparation,and pharmaceutical compositions containing these
PL246418A1 (en) Process for preparing n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
ES468675A1 (es) Procedimiento de fabricacion de tiobencilpirimidinas y sus compuestos medicamentosos.
ES459963A1 (es) Procedimiento para la obtencion de 1-(aralcoxifenilo azaci- clico)-2- o -3-(bis-arilalquilamino)-alcanos.
AU2587284A (en) N-(1-oxo-2,4,6-cycloheptatrienyl)-21+-1,2-benzothiazine-3- carboxamido 1,1-dioxide
EP0177897A3 (en) Antibacterial 7beta-heterocyclic-cephem
ATE32893T1 (de) Spirobenzofuranone, deren herstellung und verwendung.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108